SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-000859
Filing Date
2024-02-07
Accepted
2024-02-07 16:16:31
Documents
83
Period of Report
2023-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q pahc-20231231x10q.htm   iXBRL 10-Q 2299401
2 EX-31.1 pahc-20231231xex31d1.htm EX-31.1 8161
3 EX-31.2 pahc-20231231xex31d2.htm EX-31.2 8143
4 EX-32.1 pahc-20231231xex32d1.htm EX-32.1 3884
5 EX-32.2 pahc-20231231xex32d2.htm EX-32.2 4162
  Complete submission text file 0001558370-24-000859.txt   8770882

Data Files

Seq Description Document Type Size
6 EX-101.SCH pahc-20231231.xsd EX-101.SCH 50054
7 EX-101.CAL pahc-20231231_cal.xml EX-101.CAL 75212
8 EX-101.DEF pahc-20231231_def.xml EX-101.DEF 248688
9 EX-101.LAB pahc-20231231_lab.xml EX-101.LAB 383945
10 EX-101.PRE pahc-20231231_pre.xml EX-101.PRE 403504
85 EXTRACTED XBRL INSTANCE DOCUMENT pahc-20231231x10q_htm.xml XML 1700236
Mailing Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666
Business Address GLENPOINTE CENTRE EAST, 3RD FLOOR 300 FRANK W. BURR BLVD., SUITE 21 TEANECK NJ 07666 201-329-7300
PHIBRO ANIMAL HEALTH CORP (Filer) CIK: 0001069899 (see all company filings)

IRS No.: 131840497 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-36410 | Film No.: 24604525
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)